INS and Hyperglycemia: The former attempts to compensate for defects in insulin secretion and insulin action by approaches for insulin signaling regulation; meanwhile, the latter is used for controlling postprandial hyperglycemia by mitigating the activity of glucosidases, thus reducing gut glucose absorption [4].